Inventor · disambiguated record
Min Teng
Also filed as: TENG MIN · Teng min-liang
96 granted patents·12 pending applications·4,034 citations·filing 1992–2024
99Inventor score
Files withALLERGAN INC36ALLERGAN SALES INC23AGOURON PHARMA10BLACKSMITH MEDICINES INC9FORGE THERAPEUTICS INC9
Top patents by PatentIndex Score
108 records- 0199US5919970ASubstituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activityALLERGAN SALES INC·Filed 1997·Granted Jul 6, 1999·227 cites·19 claims
- 0298US6884890B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted Apr 26, 2005·178 cites·32 claims
- 0398US6534524B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2001·Granted Mar 18, 2003·277 cites·14 claims
- 0498US5663357ASubstituted heteroarylamides having retinoid-like biological activityALLERGAN INC·Filed 1995·Granted Sep 2, 1997·97 cites·19 claims
- 0597US5877207ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1997·Granted Mar 2, 1999·245 cites·34 claims
- 0697US5648514ASubstituted acetylenes having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Jul 15, 1997·69 cites·16 claims
- 0797US5514825AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted May 7, 1996·87 cites·17 claims
- 0897US5498755ADisubstituted aryl and heteroaryl imines having retinoid-like biological activityFiled 1994·Granted Mar 12, 1996·94 cites·7 claims
- 0996US6555690B2Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 2002·Granted Apr 29, 2003·43 cites·12 claims
- 1096US5958954ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1997·Granted Sep 28, 1999·176 cites·46 claims
- 1196US5648503AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Jul 15, 1997·78 cites·12 claims
- 1296US5605915AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Feb 25, 1997·74 cites·18 claims
- 1396US5599967AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Feb 4, 1997·65 cites·16 claims
- 1496US5543534AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Aug 6, 1996·81 cites·23 claims
- 1595US6818775B2Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 2003·Granted Nov 16, 2004·36 cites·11 claims
- 1695US6720425B2Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 2002·Granted Apr 13, 2004·36 cites·14 claims
- 1795US6521624B1Synthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN INC·Filed 2000·Granted Feb 18, 2003·39 cites·11 claims
- 1895US6090810ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1998·Granted Jul 18, 2000·59 cites·38 claims
- 1995US5952345ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1997·Granted Sep 14, 1999·83 cites·31 claims
- 2095US5773594AAlkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 1996·Granted Jun 30, 1998·67 cites·11 claims
- 2195US5618931AAcetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Apr 8, 1997·67 cites·43 claims
- 2294US6653483B1Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityFiled 2000·Granted Nov 25, 2003·36 cites·15 claims
- 2394US6455701B1Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activityALLERGAN INC·Filed 2000·Granted Sep 24, 2002·27 cites·5 claims
- 2494US6228848B1Synthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN INC·Filed 1999·Granted May 8, 2001·65 cites·14 claims
- 2594US6008204ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1998·Granted Dec 28, 1999·55 cites·10 claims
- 2693US8877761B2N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitorsLI HUI·Filed 2012·Granted Nov 4, 2014·19 cites·17 claims
- 2793US6610744B2Methods of treatment with compounds having RARα receptor specific or selective activityALLERGAN INC·Filed 2001·Granted Aug 26, 2003·42 cites·4 claims
- 2893US5763635ATetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 1996·Granted Jun 9, 1998·54 cites·36 claims
- 2993US5723666AOxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 1996·Granted Mar 3, 1998·71 cites·36 claims
- 3093US5654469AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Aug 5, 1997·49 cites·35 claims
- 3193US5618943AAcetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Apr 8, 1997·66 cites·32 claims
- 3293US5591858AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Jan 7, 1997·61 cites·19 claims
- 3392US6235923B1Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activityALLERGAN SALES INC·Filed 2000·Granted May 22, 2001·42 cites·17 claims
- 3492US5965606AMethods of treatment with compounds having RAR.sub.α receptor specific or selective activityALLERGAN SALES INC·Filed 1995·Granted Oct 12, 1999·83 cites·2 claims
- 3592US5739338AN-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activityALLERGAN INC·Filed 1996·Granted Apr 14, 1998·119 cites·36 claims
- 3691US7132533B2Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapyAGOURON PHARMA·Filed 2005·Granted Nov 7, 2006·21 cites·3 claims
- 3791US6891044B2Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 10, 2005·20 cites·43 claims
- 3891US6187950B1Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biologicalFiled 1999·Granted Feb 13, 2001·33 cites·7 claims
- 3991US5675024AAryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activityALLERGAN INC·Filed 1995·Granted Oct 7, 1997·71 cites·25 claims
- 4090US11407740B2Antibacterial compoundsFORGE THERAPEUTICS INC·Filed 2021·Granted Aug 9, 2022·5 cites·17 claims
- 4190US9518060B2Substituted pyrrolo[3,4-c]pyrazoles as PKC kinase inhibitorsPFIZER·Filed 2014·Granted Dec 13, 2016·11 cites·10 claims
- 4290US8183255B2N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitorsLI HUI·Filed 2008·Granted May 22, 2012·12 cites·20 claims
- 4390US7462713B2Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapyAGOURON PHARMA·Filed 2006·Granted Dec 9, 2008·18 cites·9 claims
- 4490US7141587B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2004·Granted Nov 28, 2006·17 cites·9 claims
- 4590US6660755B2Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activityALLERGAN INC·Filed 2002·Granted Dec 9, 2003·16 cites·10 claims
- 4690US6344561B2O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN SALES INC·Filed 2000·Granted Feb 5, 2002·16 cites·15 claims
- 4790US6117987AAlkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist like biological activityALLERGAN SALES INC·Filed 1998·Granted Sep 12, 2000·39 cites·7 claims
- 4890US5998655AAlkylidene substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityFiled 1998·Granted Dec 7, 1999·38 cites·23 claims
- 4989US10875832B2Substituted pyrimidines for treating bacterial infectionsFORGE THERAPEUTICS INC·Filed 2019·Granted Dec 29, 2020·4 cites·16 claims
- 5089US10414735B2Substituted hydroxypyrimidinones for treating bacterial infectionsFORGE THERAPEUTICS INC·Filed 2016·Granted Sep 17, 2019·5 cites·19 claims
Showing the top 50 of 108 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Min Teng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →